ArticleBlood neoplasia2025

Phase 1 trial of venetoclax with cladribine, cytarabine, G-CSF, and mitoxantrone for AML and high-grade myeloid neoplasm.

Suravi Raychaudhuri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.